Triplet-Triplet Annihilation Upconversion-Based Photolysis: Applications in Photopharmacology.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38613491.
- Also identified by DOI 10.1002/adhm.202400354.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The emerging field of photopharmacology is a promising chemobiological methodology for optical control of drug activities that could ultimately solve the off-target toxicity outside the disease location of many drugs for the treatment of a given pathology. The use of photolytic reactions looks very attractive for a light-activated drug release but requires to develop photolytic reactions sensitive to red or near-infrared light excitation for better tissue penetration. This review will present the concepts of triplet-triplet annihilation upconversion-based photolysis and their recent in vivo applications for light-induced drug delivery using photoactivatable nanoparticles.
Medical subject headings
- Photolysis